Global Pruritus Drugs Market 2019-2023

掻痒薬の世界市場2019-2023

◆タイトル:Global Pruritus Drugs Market 2019-2023
◆商品コード:IRTNTR31704
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年7月12日
◆ページ数:143
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:Asia, Europe, North America, and ROW
◆産業分野:Health Care
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥327,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社の本調査レポートでは、掻痒薬の世界市場について調べ、掻痒薬の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、掻痒薬の市場規模をセグメンテーション別(用途別(血液掻痒、腫瘍性そう痒症、腎掻痒、内分泌掻痒、胆汁掻痒)、)と地域別(Asia, Europe, North America, and ROW)に分けて算出しました。Technavio社は掻痒薬の世界市場規模が2019-2023期間中に年平均5%成長すると予測しています。
・サマリー
・レポートの範囲
・掻痒薬の市場状況
・掻痒薬の市場規模
・掻痒薬の市場予測
・掻痒薬の世界環境:ファイブフォース分析
・市場セグメンテーション:用途別(血液掻痒、腫瘍性そう痒症、腎掻痒、内分泌掻痒、胆汁掻痒)
・掻痒薬の顧客状況
・主要地域別市場規模:Asia, Europe, North America, and ROW
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...

Global Pruritus Drugs Market: About this market

Pruritus drugs are used to treat itches associated with skin or systemic diseases. Technavio’s pruritus drugs market analysis considers sales from the topical, oral, and parenteral segments. The market is also segmented based on application into hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus. Our analysis also considers the sales of pruritus drugs in Asia, Europe, North America, and ROW. In 2018, the hematologic pruritus segment held the highest market share. However, the oncological pruritus segment will lead in terms of market share over the forecast period owing to rising oncological indications that cause pruritus. Almost all types of cancers put patients at increased risk of developing pruritus. Also, our global pruritus drugs report has observed market growth factors such as the growing preference for immunotherapy and rising prevalence of chronic diseases. However, the availability of alternative therapies, complex pathogenesis, and poor patient adherence may hamper the growth of the pruritus drugs industry over the forecast period.

Global Pruritus Drugs Market: Overview

Growing preference for immunotherapy

The rising use of immunotherapy drugs to treat oncological indications is increasing the incidence of pruritus. As a result, the demand for pruritus drugs such as topical emollients, antihistamines, and topical corticosteroids is increasing. The high efficacy of immunotherapy in treat cancer is not allowing patients to withdraw from the treat. Therefore, the growing preference for immunotherapy will help market vendors in increasing sales. This will contribute to the growth of the global pruritus drugs market at over 5% CAGR during the forecast period.

Nanoparticle-enabled transdermal drug delivery systems

Transdermal drug delivery is not effective in the delivery of small and lipophilic drugs. As a result, vendors have come up with nanoparticle-enabled transdermal drug delivery systems, which provide faster onset of action. They are also less painful compared with routes that require incisions. Moreover, biodegradable nanoparticles can prolong the duration of drug adhesion. These factors will increase the adoption of nanoparticle-enabled transdermal drug delivery systems, which will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global pruritus drugs market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global pruritus drugs market is fragmented. Technavio’s robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading Pruritus Drugs manufacturers, which include Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., and Sanofi.

Also, the pruritus drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY APPLICATION

Market segmentation by application

Comparison by application

Hematologic pruritus – Market size and forecast 2018-2023

Oncological pruritus – Market size and forecast 2018-2023

Renal pruritus – Market size and forecast 2018-2023

Endocrine pruritus – Market size and forecast 2018-2023

Cholestatic pruritus – Market size and forecast 2018-2023

Market opportunity by application

PART 08: MARKET SEGMENTATION BY ROA

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 15: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Allergan Plc

Astellas Pharma Inc.

GlaxoSmithKline Plc

Pfizer Inc.

Sanofi

PART 16: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

Exhibit 01: Product overview

Exhibit 02: Global pharmaceuticals market

Exhibit 03: Segments of global pharmaceuticals market

Exhibit 04: Market characteristics

Exhibit 05: Market segments

Exhibit 06: Market definition – Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Five forces analysis 2018

Exhibit 11: Five forces analysis 2023

Exhibit 12: Bargaining power of buyers

Exhibit 13: Bargaining power of suppliers

Exhibit 14: Threat of new entrants

Exhibit 15: Threat of substitutes

Exhibit 16: Threat of rivalry

Exhibit 17: Market condition – Five forces 2018

Exhibit 18: Global pruritus drugs market pipeline: Overview

Exhibit 19: Global pruritus drugs market pipeline: Snapshot

Exhibit 20: Application – Market share 2018-2023 (%)

Exhibit 21: Comparison by application

Exhibit 22: Hematologic pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Hematologic pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 24: Oncological pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Oncological pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 26: Renal pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 27: Renal pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 28: Endocrine pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 29: Endocrine pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 30: Cholestatic pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: Cholestatic pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 32: Market opportunity by application

Exhibit 33: RoA – Market share

Exhibit 34: Few prominent topical drugs

Exhibit 35: Customer landscape

Exhibit 36: Market share by geography 2018-2023 (%)

Exhibit 37: Geographic comparison

Exhibit 38: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: North America – Year-over-year growth 2019-2023 (%)

Exhibit 40: Top 3 countries in North America

Exhibit 41: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 42: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 43: Top 3 countries in Europe

Exhibit 44: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 45: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 46: Top 3 countries in Asia

Exhibit 47: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 48: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 49: Top 3 countries in ROW

Exhibit 50: Key leading countries

Exhibit 51: Market opportunity

Exhibit 52: Indications that are associated with pruritus

Exhibit 53: Impact of drivers and challenges

Exhibit 54: Vendor landscape

Exhibit 55: Landscape disruption

Exhibit 56: Vendors covered

Exhibit 57: Vendor classification

Exhibit 58: Market positioning of vendors

Exhibit 59: Allergan Plc – Vendor overview

Exhibit 60: Allergan Plc – Business segments

Exhibit 61: Allergan Plc – Organizational developments

Exhibit 62: Allergan Plc – Geographic focus

Exhibit 63: Allergan Plc – Segment focus

Exhibit 64: Allergan Plc – Key offerings

Exhibit 65: Allergan Plc – Key customers

Exhibit 66: Astellas Pharma Inc. – Vendor overview

Exhibit 67: Astellas Pharma Inc. – Business segments

Exhibit 68: Astellas Pharma Inc. – Organizational developments

Exhibit 69: Astellas Pharma Inc. – Geographic focus

Exhibit 70: Astellas Pharma Inc. – Key offerings

Exhibit 71: Astellas Pharma Inc. – Key customers

Exhibit 72: GlaxoSmithKline Plc – Vendor overview

Exhibit 73: GlaxoSmithKline Plc – Business segments

Exhibit 74: GlaxoSmithKline Plc – Organizational developments

Exhibit 75: GlaxoSmithKline Plc – Geographic focus

Exhibit 76: GlaxoSmithKline Plc – Segment focus

Exhibit 77: GlaxoSmithKline Plc – Key offerings

Exhibit 78: GlaxoSmithKline Plc – Key customers

Exhibit 79: Pfizer Inc. – Vendor overview

Exhibit 80: Pfizer Inc. – Business segments

Exhibit 81: Pfizer Inc. – Organizational developments

Exhibit 82: Pfizer Inc. – Geographic focus

Exhibit 83: Pfizer Inc. – Segment focus

Exhibit 84: Pfizer Inc. – Key offerings

Exhibit 85: Pfizer Inc. – Key customers

Exhibit 86: Sanofi – Vendor overview

Exhibit 87: Sanofi – Business segments

Exhibit 88: Sanofi – Organizational developments

Exhibit 89: Sanofi – Geographic focus

Exhibit 90: Sanofi – Segment focus

Exhibit 91: Sanofi – Key offerings

Exhibit 92: Sanofi – Key customers

Exhibit 93: Validation techniques employed for market sizing

Exhibit 94: Definition of market positioning of vendors



【掲載企業】

Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., and Sanofi.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[掻痒薬の世界市場2019-2023]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆